Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipramine for AIDS-related depression
NCT00000390Phase 2Completed
- Sponsor
- Novartis
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing Imipramine hydrochloride with Placebo (2 arms). Primary endpoint: Hamilton Depression Rating Scale at 6 weeks. Status: completed.
02
Drugs
imipramine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00000390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000390.